HOME >> MEDICINE >> NEWS
Could reality TV save academic medicine?

Imagine a future where medical schools are answerable to shareholders, where patients decide how doctors should be trained, or where academics compete on TV game shows to win research grants

This could be the future of academic medicine by 2025, according to members of the International Campaign to Revitalise Academic Medicine (ICRAM), launched by the BMJ and partners in November 2003.

Their vision for the future is published simultaneously today by the BMJ (www.bmj.com), the open access international medical journal PLoS Medicine (www.plosmedicine.org) and the Milbank Memorial Fund (www.milbank.org).

In the first scenario, academic medicine flourished in the private sector and medical research, training and service became commercial business activities. But, although overall efficiency and effectiveness improved, equity and innovation suffered.

Academic medicine disappeared altogether in the second scenario. Instead, teaching, learning, and researching were integrated with mainstream health care. Team work fostered, but stability and decision making was threatened.

In scenario three, the public were in charge. They determined research priorities through game shows or citizen's juries and students received most of their training from expert patients. But scientific advances were subject to fads and there was little regulation of health information.

In the final two scenarios, academic medicine engaged fully with all stakeholders and focused on improving global health. Global networks flourished and medical training was energised. But lack of political will and fears of "dumbing down" hampered progress.

"None of these scenarios will come to exist as we have described them, but the future is likely to contain some elements from each of them," say the authors. "Our main hope is that o
'"/>

Contact: Paul Ocampo
press@plos.org
415-624-1224
Public Library of Science
4-Jul-2005


Page: 1 2

Related medicine news :

1. Could statins be a new option for hepatitis C patients?
2. Could the ability to expel worms lead to a future asthma treatment?
3. Could dental disease contribute to increased risk of stroke?
4. Could a popular HIV drug benefit hepatitis B patients?
5. Could a simple test save Medicare hundreds of millions?
6. Could exercise protect older people from hip fracture?
7. Cant serve an ace? Could be muscle fatigue
8. Social connections: Could heartwarming be heart-saving?
9. Our grip on reality is slim, says UCL scientist
10. The $6 billion (hu)man is becoming reality, as bionics restores or expands humans abilities
11. Fringe plastic surgery procedures more hype than reality, ASPS says

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Could reality save academic medicine

(Date:10/22/2014)... Akeso Biomedical, Inc. , a privately held ... infections, microbial biofilms, and chronic wounds, announced that Dr. ... , Dr. Sinskey is a Professor ... of Technology, or MIT. He has been a member ... holds positions as Co-Director of the Malaysia-MIT Biotechnology Partnership ...
(Date:10/22/2014)... TUESDAY, Oct. 21, 2014 (HealthDay News) -- Two sisters ... and heart damage. Ilina and Medha Krishen use ... for sounds of trouble in breathing patterns or heartbeats. ... School in Michigan, wanted to find a way to ... air pollutants. Using an electronic stethoscope, Ilina recorded one ...
(Date:10/22/2014)... 2014 (HealthDay News) -- Measures taken by Firestone officials ... Liberia may have limited the spread of the disease ... The Firestone Natural Rubber Co. provides health services to ... nearby densely populated communities. Between Aug. 1 and ... cases among those 80,000 people. That incidence rate of ...
(Date:10/20/2014)... 20, 2014 The newly updated Worldwide ... of thousands of facts, figures and forecasts on the ... medical sector forecast categories the Worldwide Medical Market ... and national views on the worldwide medical market to ... report gives you data for 2010-2019, covering each country ...
(Date:10/20/2014)... October 20, 2014 The Advocator ... booth at the American Foundation for Suicide Prevention’s (AFSP) ... AFSP is a not-for-profit organization that hosts hundreds of ... from these events are used to help understand and ... and personal relationships as well. , The Advocator ...
Breaking Medicine News(10 mins):Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3
(Date:10/22/2014)... October 22, 2014 Oramed ... a clinical-stage pharmaceutical company focused on the development ... top-line clinical results from its Phase IIa clinical ... capsules, to treat type 1 diabetes. The trial was ... under a U.S. Food and Drug Administration ...
(Date:10/22/2014)... Colo. , Oct. 22, 2014   Surefire ... of infusion systems designed to maximize targeted delivery of ... pleased to announce that oncologist John R. Daniels ... Comprehensive Cancer Center, and surgical oncologist Steven C. ... have joined the Company,s Scientific Advisory Board (SAB).    ...
(Date:10/22/2014)... NEW YORK , Oct. 22, 2014 ... and dermatology therapies. PV-10, its novel investigational drug for ... the potential for systemic side effects. Its oncology focus ... liver. Provectus has completed phase 2 trials of PV-10 ... as a topical treatment for atopic dermatitis and psoriasis. ...
Breaking Medicine Technology:Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2
Cached News: